169 related articles for article (PubMed ID: 21697700)
1. Distinction of melanoma in situ from solar lentigo on sun-damaged skin using morphometrics and MITF immunohistochemistry.
Black WH; Thareja SK; Blake BP; Chen R; Cherpelis BS; Glass LF
Am J Dermatopathol; 2011 Aug; 33(6):573-8. PubMed ID: 21697700
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
[TBL] [Abstract][Full Text] [Related]
3. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
[TBL] [Abstract][Full Text] [Related]
4. S100-negative junctional melanocytic proliferations.
Wilson ML; Hossler EW; Ferringer TC; Elston DM
Am J Dermatopathol; 2011 May; 33(3):327-9. PubMed ID: 20940618
[No Abstract] [Full Text] [Related]
5. An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ.
Hillesheim PB; Slone S; Kelley D; Malone J; Bahrami S
J Cutan Pathol; 2011 Jul; 38(7):565-9. PubMed ID: 21362015
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.
Helm K; Findeis-Hosey J
J Cutan Pathol; 2008 Oct; 35(10):931-4. PubMed ID: 18494818
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of MITF, SOX10, MART-1, and R21 Immunostaining for the Diagnosis of Residual Melanoma In Situ on Chronically Sun-Damaged Skin.
Mu EW; Quatrano NA; Yagerman SE; Ratner D; Meehan SA
Dermatol Surg; 2018 Jul; 44(7):933-938. PubMed ID: 29419543
[TBL] [Abstract][Full Text] [Related]
8. Morphometric discrimination of melanoma in situ of sun-damaged skin from chronically sun-damaged skin.
Acker SM; Nicholson JH; Rust PF; Maize JC
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):239-45. PubMed ID: 9704836
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ.
Kim J; Taube JM; McCalmont TH; Glusac EJ
J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920
[TBL] [Abstract][Full Text] [Related]
10. [Lentigo maligna: a diagnostic and therapeutic challenge].
Alcalay J
Harefuah; 2014 May; 153(5):259-60, 306, 305. PubMed ID: 25112116
[TBL] [Abstract][Full Text] [Related]
11. Melanocyte Density in the Diagnosis of Melanoma In Situ in Sun-Damaged Skin.
Löper R; Schön MP; Mitteldorf C
Am J Dermatopathol; 2024 Jun; 46(6):358-364. PubMed ID: 38513120
[TBL] [Abstract][Full Text] [Related]
12. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
Magro CM; Yang SE; Zippin JH; Zembowicz A
Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic hyperplasia in sun-exposed skin has been defined.
Hendi A; Brodland D; Zitelli JA
Dermatol Surg; 2011 Apr; 37(4):550. PubMed ID: 21481072
[No Abstract] [Full Text] [Related]
14. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
Bene NI; Healy C; Coldiron BM
Dermatol Surg; 2008 May; 34(5):660-4. PubMed ID: 18261099
[TBL] [Abstract][Full Text] [Related]
15. Management of lentigo maligna.
Christenson LJ
Dermatol Nurs; 2004 Dec; 16(6):495-8, 505, 523. PubMed ID: 15690926
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
Bowen AR; Thacker BN; Goldgar DE; Bowen GM
Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
[TBL] [Abstract][Full Text] [Related]
18. Melanocytes in nonlesional sun-exposed skin: a multicenter comparative study.
Hendi A; Wada DA; Jacobs MA; Crook JE; Kortuem KR; Weed BR; Otley CC; Gibson LE
J Am Acad Dermatol; 2011 Dec; 65(6):1186-93. PubMed ID: 21684036
[TBL] [Abstract][Full Text] [Related]
19. Unstable solar lentigo: A defined separate entity.
Byrom L; Barksdale S; Weedon D; Muir J
Australas J Dermatol; 2016 Aug; 57(3):229-34. PubMed ID: 26832231
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous occurrence of multiple melanoma in situ on sun-damaged skin (lentigo maligna), solar lentigo and labial melanosis: the value of dermoscopy in diagnosis.
Massi D; Nardini P; De Giorgi V; Carli P
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):193-7. PubMed ID: 10642055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
